Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID‐19 Patients
Background. Tissue damage caused by COVID‐19 could be detected by several clinical
indicators including hematological, immunological, biochemical, and inflammatory markers …
indicators including hematological, immunological, biochemical, and inflammatory markers …
[HTML][HTML] Role of inflammatory and liver function markers in assessing the prognosis of patients with COVID‑19
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) caused Coronavirus
disease 2019 (COVID‑19) in early December, 2019. The disease begins as a respiratory …
disease 2019 (COVID‑19) in early December, 2019. The disease begins as a respiratory …
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors
H Han, Q Ma, C Li, R Liu, L Zhao, W Wang… - Emerging microbes & …, 2020 - Taylor & Francis
Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, it has rapidly
spread across many other countries. While the majority of patients were considered mild …
spread across many other countries. While the majority of patients were considered mild …
[HTML][HTML] The immune, inflammatory and hematological response in COVID-19 patients, according to the severity of the disease
Introduction: The aim of this study was to evaluate the immune and inflammatory responses
in COVID-19 patients by dosing specific IgM and IgG total antibodies and interleukin 6 …
in COVID-19 patients by dosing specific IgM and IgG total antibodies and interleukin 6 …
[HTML][HTML] IL1β, IL-6, and TNF-α cytokines cooperate to modulate a complicated medical condition among COVID-19 patients: case-control study
SS Faraj, PJ Jalal - Annals of Medicine and Surgery, 2023 - journals.lww.com
Background: The cytokine storm is a complication related to SARS-CoV-2 infection
worldwide. This study aimed to address the level of three cytokines which were interleukin-1 …
worldwide. This study aimed to address the level of three cytokines which were interleukin-1 …
[HTML][HTML] Implications of SARS-CoV-2 infection on the clinical, hematological, and inflammatory parameters in COVID-19 patients: A retrospective cross-sectional study
LA Damiati, S Bahlas, A Aljohaney, Y Bawazir… - Journal of Infection and …, 2022 - Elsevier
Background The current coronavirus pandemic (COVID-19) was caused by severe acute
respiratory syndrome virus 2 (SARS-CoV-2). COVID-19 is characterized by atypical …
respiratory syndrome virus 2 (SARS-CoV-2). COVID-19 is characterized by atypical …
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19
W Sayah, I Berkane, I Guermache, M Sabri, FZ Lakhal… - Cytokine, 2021 - Elsevier
Accumulating evidence supports that the viral-induced hyper-inflammatory immune
response plays a central role in COVID-19 pathogenesis. It might be involved in the …
response plays a central role in COVID-19 pathogenesis. It might be involved in the …
[HTML][HTML] Role of laboratory biomarkers in assessing the severity of COVID-19 disease. A cross-sectional study
DJ Nizami, V Raman, L Paulose… - Journal of Family …, 2021 - journals.lww.com
Background: Corona virus disease 2019 (Covid-19) has high infectivity and mortality rate.
Covid-19 patients can suddenly deteriorate and develop life threatening complications …
Covid-19 patients can suddenly deteriorate and develop life threatening complications …
[HTML][HTML] Characteristics of lymphocyte subsets and inflammatory factors in patients with COVID-19
Z Chen, J Li, J Zheng, F Xiang, X Li, M Zhang, X Kang… - Heliyon, 2024 - cell.com
Objective This research aims to examine the involvement of lymphocyte subsets and
inflammatory cytokines in the development and progression of COVID-19. Methods 164 …
inflammatory cytokines in the development and progression of COVID-19. Methods 164 …
Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study
QQ Liu, A Cheng, Y Wang, H Li, L Hu, X Zhao… - BMJ open, 2020 - bmjopen.bmj.com
Objective To delineate the characteristics and clinical significance of plasma inflammatory
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …